South Tongu Transport Operators Divided Over TRAFFITECH-GH Implementation
September 16, 2026
Press Releases
Meltwater Wins 2026 PRWeek Global Award for “Best PR Software or AI Platform”
May 20, 2026
The award recognizes Meltwater’s AI-powered innovations that provide actionable intelligence for PR, Communications and Marketing teams SAN FRANCISCO, May 20, 2026 (GLOBE NEWSWIRE) — Meltwater, the global leader in actionable intelligence for PR, Communications and Marketing teams, has been awarded the PRWeek
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
May 19, 2026
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
May 19, 2026
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
May 19, 2026
ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
May 19, 2026
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
May 19, 2026
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
May 19, 2026
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug
Bitget Launches UEX Jumpstart Program With 430K USDT Rewards
May 19, 2026
Bitget Launches UEX Jumpstart Program With 430K USDT Rewards VICTORIA, Seychelles, May 19, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched the UEX Jumpstart Program, a multi-product onboarding initiative featuring a total prize pool of
RECENT POST
South Tongu Transport Operators Divided Over TRAFFITECH-GH Implementation
September 16, 2026
GRA Challenges GHS79.65 Million Court Award to Servestar Minwax
September 16, 2026
DVLA Calls for Support in New License Plate Regime Implementation
September 16, 2026
Raheem Sterling Faces Up to 2 Years in Prison After Nitrous Oxide Possession
September 16, 2026
UDS Achieves Historic Back-to-Back Wins at All Africa University Games
September 16, 2026
Messi to Play Final International Match Against Benin in Farewell Friendly
September 16, 2026
AFCON: Carlos Queiroz Set to Axe Some World Cup Players
September 16, 2026
AFCON Qualifiers: C´te d’Ivoire Release Squad Ahead of Ghana Clash
September 16, 2026